Shafique Virani, Chief Business Officer: Recursion Pharmaceuticals RXRX Sell · Filed 23/08/17

Trade details

Type: Insider sale
Amount: $166,500
Shares · price: 18,000 sh · $9.25 a share
Held after: 140,351 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Shafique ViraniChief Business Officer
Trade date: 23/08/15
Filed: 23/08/17
Days to filing: 2 days

Sold 11.4% of holdings

Share of holding sold: 11.4%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/07/16~23/09/14

Shafique Virani's recent trades

Shafique ViraniChief Business Officer
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$196.7K
18,000 sh
$196.7K
Filed 24/01/18
Traded 24/01/16
Shafique ViraniChief Business Officer
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$172.8K
18,000 sh
$172.8K
Filed 23/12/19
Traded 23/12/15
Shafique ViraniChief Business Officer
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$117.2K
18,000 sh
$117.2K
Filed 23/11/17
Traded 23/11/15
Shafique ViraniChief Business Officer
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$113.4K
18,000 sh
$113.4K
Filed 23/10/18
Traded 23/10/16
Shafique ViraniChief Business Officer
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$155.9K
18,000 sh
$155.9K
Filed 23/09/19
Traded 23/09/15

Shafique Virani, Chief Officer — sold $166.5K of Recursion Pharmaceuticals RXRX · 11.4% of holdings · 10b5-1 plan | Whalegun